FDA approves pembrolizumab plus lenvatinib combination for advanced kidney cancer
The US Food and Drug Administration (FDA) has approved the [...]
The US Food and Drug Administration (FDA) has approved the [...]
Results from a phase Ib/II study looking at lenvatinib plus [...]
The KEYNOTE-426 study of the immune checkpoint inhibitor, pembrolizumab plus [...]
Results from the phase 3 CLEAR study were presented at [...]
Adjuvant therapy is medication that is given in addition to [...]
Interim results from a phase 3 clinical trial called KEYNOTE-564 [...]
This Practice Update interview with Dr Monty Pal from City [...]
Results from the phase 3 CLEAR study, presented at the [...]
The recent phase II KEYNOTE-427 study investigated the efficacy and [...]
Results from the phase 3 KEYNOTE-581/CLEAR trial show that the [...]